Mezoo was established in 2007 in Wonju, Korea. We originally started as an R&D firm that develop wearable Holter, invasive blood glucose algorithm, 3/5/12 lead ECGs, IoMT Platform, and the HiCardi system.

The area of biomedical engineering that we focus on is the development and manufacturing of wearable SmartPatches, mobile, and web-based software.

For that, we are committed to developing new Mobile Cardiac Technologies, such as the worlds smallest biosensors, reliable and precise bio-signal measurements. We believe that our innovative remote/real-time/wireless HiCardi system supports medical professionals monitoring and managing patients who suffering from cardiac disorders.

Biomedical Sensor Technology
Biomedical Signal Processing Algorithm
IoMT Solutions
Mobile Cardiac Telemetry

Our company mission is to improve human race health by providing accurate diagnoses. We start with the smallest bio-processor for measuring various vital signs and expand the business area to medical grade monitoring and diagnosis platform assisted by artificial intelligence.

Our company reinvents cardiology and vital signs by leveraging cloud-based technology and medical grade AI platform.